Track STIM and 10,000+ stocks
Create a free account to build watchlists, compare peers, and value any stock.
- Build and track watchlists
- Compare against peers
- Earnings & price alerts
No credit card required
Main
Market Cap$121.08M
Enterprise Value$179.10M
Revenue (TTM)$151.64M
Net Income (TTM)-$37.11M
Free Cash Flow (TTM)-$13.58M
Financial Health
Cash$13.21M
Net Debt$58.02M
Debt Ratio0.57
Debt to Equity5.37
Interest Coverage-3.97
Valuation (TTM)
Price to Sales0.8
Price to Earnings-3.26
EV to EBITDA-6.79
Price to Book9.13
Price to Free Cash Flow-8.92
Margins (TTM)
Gross Profit Margin47.96%
EBITDA Margin-17.39%
Operating Income Margin-19.40%
Net Income Margin-24.48%
Free Cash Flow Margin-8.96%
Returns (5Y Avg)
Return on Invested Capital-30.19%
Return on Assets-25.41%
Return on Equity-104.41%
Return on Total Capital-30.19%
Return on Capital Employed-31.11%
Dividend Summary
Dividend Yield-
Annual Dividend-
Payout Ratio-
Ex Dividend Date-
5-Year Dividend CAGR-
CAGR (5Y)
Revenue24.81%
Diluted EPS13.42%
Total Debt15.17%
Capital Expenditures1.87%
Free Cash Flow20.14%
CAGR (3Y)
Revenue31.76%
Diluted EPS21.61%
Total Debt24.73%
Capital Expenditures-37.42%
Free Cash Flow221.28%
CAGR (1Y)
Revenue99.17%
Diluted EPS62.46%
Total Debt19.06%
Capital Expenditures-45.36%
Free Cash Flow1000.00%
$1.87-$0.01|-0.32%
Last updated: Jul 21, 4:07 PM ET
52W High$4.85
52W Low$0.80
50D SMA$1.42
200D SMA$1.71
Volume2.84M
Neuronetics Inc
3222 Phoenixville Pike, Malvern, PA, United States, 19355
IPO
2018
Employees
658
Industry
Medical Devices
Sector
Healthcare
Neuronetics, Inc. engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally. The company provides NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. Neuronetics, Inc. has a strategic collaboration with ANT Neuro to expand the capabilities of the NeuroStar advanced therapy system with advanced image-guided navigation technology. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.
Insider Transactions
Quarterly buy vs. sell activity
Sell (left)Buy (right)
Q2 20260+1
1
Q1 20269-5
4
Q2 20251-1
0
3-quarter cumulative
10 sells5 buys
Analyst Ratings
3 analysts covering
Buy67%recommend buy
Buy
2
Hold
1
Sell
0